What is the equity of Evogene this year?
Evogene has equity of 12.05 M USD this year.
Evogene Equity 2024
Evogene Equity
12.05 M USD
Ticker
EVGN
ISIN
IL0011050551
WKN
A0Q7UP
In 2024, Evogene's equity was 12.05 M USD, a -56.8% increase from the 27.9 M USD equity in the previous year.
Evogene Aktienanalyse
What does Evogene do?
Evogene Ltd is an Israeli biotechnology company that focuses on the application of computational biology and genomics to agriculture and biology. The company originated from a spin-off of the Weizmann Institute of Science and was founded in 2002. Today, it is a leading global provider of biotechnology solutions for the agriculture and biotechnology industry. Evogene's business model is based on providing innovative technologies and services for its customers, aiming to improve plant development, particularly in terms of resistance to environmental stress factors and pests. To achieve this, the company utilizes modern biotechnology methods and leverages artificial intelligence. It employs advanced machine learning and large-scale data analysis techniques to gain a better understanding of underlying biological processes. Evogene operates in three core areas: agricultural biotechnology, drug discovery biotechnology, and biomaterials. The company is capable of offering customized biological solutions tailored to the specific needs of its customers. Agricultural biotechnology is one of Evogene's key sectors. It utilizes state-of-the-art technologies and methods to generate plant resistance to pests and environmental factors. With the help of a reliable pipeline of innovative products such as seeds, biostimulants, and fertilizers, Evogene aims to play an important role in food security, environmental sustainability, and resilience to climate change. The company has a strong product pipeline aimed at improving nutrient efficiency of crops while reducing environmental impact from pesticide and fertilizer use. One such product resulting from this pipeline is EvoCanna, which utilizes modern genomics methods to optimize hemp plants in terms of phytocannabinoid biosynthesis. The goal of Evogene's drug discovery biotechnology and biomaterials sector is to develop innovative and effective medicines for diseases such as cancer and obesity. The company utilizes modern machine learning and large-scale data analysis methods to identify the potential of new drug candidates. In the biomaterials sector, Evogene aims to develop innovative technologies and solutions for better and more sustainable use of natural resources. An important application of this concept is biostimulants, which can improve the growth rate, stress tolerance, and yield of crops. Additionally, the company can offer new materials and environmentally friendly solutions in the packaging industry. Overall, Evogene has achieved impressive success in recent years and established itself as a leading biotechnology company. By utilizing cutting-edge technologies, methods, and scientific concepts, particularly artificial intelligence and machine learning, and by operating as a responsible company in the fields of agriculture, biomaterials, and programming, Evogene is able to offer innovative biotechnological solutions. The company is currently well-equipped and has a promising pipeline of groundbreaking innovation projects that embody the desire for a sustainable worldview. Evogene ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Evogene's Equity
Evogene's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Evogene's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Evogene's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Evogene's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Evogene’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Evogene stock
What was the equity of Evogene compared to the previous year?
The equity of Evogene has increased/decreased by -56.8% decreased compared to the previous year.
What impact does a high equity have on investors of Evogene?
A high equity is advantageous for investors of Evogene as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Evogene?
A low equity can be a risk for investors of Evogene, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Evogene affect the company?
An increase in equity of Evogene can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Evogene affect the company?
A reduction in equity of Evogene can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Evogene?
Some factors that can affect the equity of Evogene include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Evogene so important for investors?
The equity of Evogene is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Evogene take to change the equity?
To change equity, Evogene can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Evogene pay?
Over the past 12 months, Evogene paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Evogene is expected to pay a dividend of 0 USD.
What is the dividend yield of Evogene?
The current dividend yield of Evogene is .
When does Evogene pay dividends?
Evogene pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Evogene?
Evogene paid dividends every year for the past 0 years.
What is the dividend of Evogene?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Evogene located?
Evogene is assigned to the 'Health' sector.
Wann musste ich die Aktien von Evogene kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Evogene from 7/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/7/2024.
When did Evogene pay the last dividend?
The last dividend was paid out on 7/7/2024.
What was the dividend of Evogene in the year 2023?
In the year 2023, Evogene distributed 0 USD as dividends.
In which currency does Evogene pay out the dividend?
The dividends of Evogene are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Evogene
Our stock analysis for Evogene Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Evogene Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.